154 related articles for article (PubMed ID: 30165098)
1. Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.
Pandi P; Jain A; Kommineni N; Ionov M; Bryszewska M; Khan W
Int J Pharm; 2018 Oct; 550(1-2):240-250. PubMed ID: 30165098
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and
Walunj M; Doppalapudi S; Bulbake U; Khan W
J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
Viegas JSR; Praça FG; Caron AL; Suzuki I; Silvestrini AVP; Medina WSG; Del Ciampo JO; Kravicz M; Bentley MVLB
Drug Deliv Transl Res; 2020 Jun; 10(3):646-660. PubMed ID: 32060883
[TBL] [Abstract][Full Text] [Related]
5. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.
Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W
Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
[TBL] [Abstract][Full Text] [Related]
8. Topical delivery of siRNA into skin using SPACE-peptide carriers.
Chen M; Zakrewsky M; Gupta V; Anselmo AC; Slee DH; Muraski JA; Mitragotri S
J Control Release; 2014 Apr; 179():33-41. PubMed ID: 24434423
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification.
Ziraksaz Z; Nomani A; Soleimani M; Bakhshandeh B; Arefian E; Haririan I; Tabbakhian M
Int J Pharm; 2013 May; 448(1):231-8. PubMed ID: 23535347
[TBL] [Abstract][Full Text] [Related]
10. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis.
Desmet E; Bracke S; Forier K; Taevernier L; Stuart MC; De Spiegeleer B; Raemdonck K; Van Gele M; Lambert J
Int J Pharm; 2016 Mar; 500(1-2):268-74. PubMed ID: 26806466
[TBL] [Abstract][Full Text] [Related]
11. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment.
Boakye CHA; Patel K; Doddapaneni R; Bagde A; Marepally S; Singh M
J Control Release; 2017 Jan; 246():120-132. PubMed ID: 27170227
[TBL] [Abstract][Full Text] [Related]
12. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques.
Marepally S; Boakye CH; Patel AR; Godugu C; Doddapaneni R; Desai PR; Singh M
Nanomedicine (Lond); 2014 Jul; 9(14):2157-74. PubMed ID: 24593003
[TBL] [Abstract][Full Text] [Related]
13. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
14. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
15. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis.
Jain A; Pooladanda V; Bulbake U; Doppalapudi S; Rafeeqi TA; Godugu C; Khan W
Nanomedicine; 2017 Oct; 13(7):2251-2262. PubMed ID: 28647592
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
17. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
18. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
19. Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers.
Pavan GM; Monteagudo S; Guerra J; Carrión B; Ocaña V; Rodríguez-Lopez J; Danani A; Pérez-Martínez FC; Ceña V
Curr Med Chem; 2012; 19(29):4929-41. PubMed ID: 22963640
[TBL] [Abstract][Full Text] [Related]
20. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
